KalVista Pharmaceuticals, Inc.
KALV
$27.00
$0.010.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 07/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 18.57% | -- | 9.87% | -- |
| Total Receivables | -- | 20.21% | -- | -47.14% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 9.44% | -- | 56.50% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 30.00% | 19.74% | 113.59% | 7.44% | 7.09% |
|
|
|||||
| Total Current Assets | 30.00% | 19.74% | 113.59% | 7.44% | 7.09% |
| Net Property, Plant & Equipment | -- | 77.44% | -- | -9.13% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 70.80% | -- | 292.89% | -- |
| Total Assets | 31.16% | 21.52% | 111.36% | 7.65% | 6.53% |
|
|
|||||
| Total Accounts Payable | -- | 41.19% | -- | -45.62% | -- |
| Total Accrued Expenses | -- | 47.75% | -- | 83.21% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 951.94% | -- | 67.88% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 34.65% | 123.91% | 103.34% | 71.23% | 98.04% |
|
|
|||||
| Total Current Liabilities | 34.65% | 123.91% | 103.34% | 71.23% | 98.04% |
| Long-Term Debt | 141.76% | 155.95% | -- | -- | 1,660.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 147.28% | -- | -19.43% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 124.33% | 158.34% | 1,103.22% | 537.67% | 439.10% |
|
|
|||||
| Common Stock & APIC | -- | 2.52% | -- | 10.88% | -- |
| Retained Earnings | -20.36% | -26.92% | -33.79% | -39.81% | -39.05% |
| Treasury Stock & Other | -- | -222.87% | -- | -122.62% | -- |
| Total Common Equity | -120.60% | -101.87% | -87.31% | -76.39% | -53.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -120.60% | -101.87% | -87.31% | -76.39% | -53.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -- | -101.87% | -- | -76.39% | -- |
|
|
|||||